SARS-CoV-2 IgM & IgG Quantum Dot Immunoassay
Mokobio SARS-CoV-2 IgM & IgG Quantum Dot Immunoassay is a single-use rapid lateral flow immunofluorescence test intended for qualitative detection and differentiation of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum and plasma (EDTA, lithium heparin or sodium citrate).
9 researchers from Tokyo University and Osaka University recently published a paper studying the serological status of symptomatic COVID-19 patients. Mokobio SARS-CoV-2 IgM & IgG Quantum Dot Immunoassay and Immunofluorescence Analyzer and were used throughout the study.
Handheld device for qualitative tests. Compatible with the SARS-CoV-2 IgM & IgG Quantum Dot Immunoassay.
For detection of IgM and IgG antibodies against SARS-CoV-2 from human clinical specimen (serum, plasma or whole blood).